Nasal corticosteroids, such as fluticasone, exert their therapeutic effect in cluster headache by reducing neurogenic inflammation through inhibition of pro-inflammatory cytokines and suppression of inflammatory cell recruitment. By modulating the hypothalamic-pituitary-adrenal axis and decreasing local inflammatory mediators, these agents can help mitigate the severity and frequency of cluster headache episodes by targeting underlying inflammatory processes.